PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 11, 2025Journal of General Internal Medicine2 citationsOpen Access

Individual and Community-level Determinants of Osteoporosis Treatment Following Fracture Among Medicare Beneficiaries

View Full Paper
HWHongke WuYLYe LiuJZJingyi Zhang

Key Points

  • To identify factors influencing osteoporosis treatment following a major fracture in Medicare beneficiaries.
  • Retrospective cohort study utilizing a 5% sample of Medicare fee-for-service claims
  • Participants included beneficiaries aged 65+ with a major osteoporotic fracture from 2017-2020
  • Primary outcome measure was initiation of osteoporosis medication within one year after fracture
  • Analysis included community social determinants of health and individual demographics using Lasso-penalized Cox models
  • Only 11.9% received osteoporosis treatment before fracture
  • 77.6% of patients were untreated both before and after fracture
  • Preventive services such as wellness visits and vaccinations increased treatment likelihood post-fracture
  • Community socioeconomic disadvantages reduced treatment rates, especially in women

Abstract

Abstract Background Despite guideline recommendations, pharmacologic treatment after osteoporotic fracture remains suboptimal. Objective To identify individual and community factors associated with osteoporosis (OP) treatment after major osteoporotic fracture, and to investigate osteoporosis treatment patterns before and after fracture. Design Retrospective cohort study using a 5% random sample of Medicare fee-for-service claims (2016–2021). Participants Medicare beneficiaries ≥ 65 years with a first major osteoporotic fracture (hip, vertebral, pelvis, humerus, femur, or radius/ulna) during 2017–2020 and ≥ 12 months of continuous enrollment before the index fracture. Main Measures Primary outcome of interest was the start of any OP medication (bisphosphonates, denosumab, teriparatide, abaloparatide, or romosozumab) within one year after fracture. Key factors included preventive-service use in the prior year, community social determinants of health (SDoH) factors derived by exploratory factor analysis, and individual demographics and comorbidities. Lasso-penalized Cox models selected essential variables and estimated adjusted hazard ratios (HRs). Key Results Only 11.9% of patients were treated before fracture and 77.6% received no treatment both before and after fracture. Preventive services were associated with increased post-fracture OP treatment in both sexes (Wellness visit HR95%CI = 1.201.04–1.38 in men, 1.020.98–1.07 in women, bone mineral density testing HR = 1.571.28–1.94 in men, 1.151.09–1.22 in women; influenza/pneumococcal vaccination HR = 1.281.09–1.49 in men, 1.131.08–1.19 in women). A community “socioeconomic barrier” factor (low income, high poverty, high mobile-home residence, uninsured) was associated with decreased post-fracture OP treatment in women (HR = 0.890.81–0.98) but not in men. Antidepressant use and history of falls were associated with decreased post-fracture OP treatment in both sexes. Conclusions OP treatment after fracture remains suboptimal—especially among men—despite clear guidelines. Engagement with preventive care was strongly associated with treatment initiation. Community socioeconomic disadvantage and depression were also important barriers to post-fracture treatment, with sex-specific patterns. Integrating fracture-care pathways into preventive visits and focusing on socioeconomically disadvantaged communities could improve secondary fracture prevention.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/69401b262d562116f28f7813https://doi.org/10.1007/s11606-025-10090-y
Ask AI
Helpful
Bookmark
Share
View Full Paper